Clincosm LogoSign in Get a demo

AML: Conventional and Experimental Chemotherapy With Allogeneic Transplant in Young Patients With Acute Myeloid Leukaemia

Sponsor
Azienda Ospedaliera San Giovanni Battista (Other)
Overall Status
Unknown status
CT.gov ID
NCT01785953
Collaborator
(none)
300
Enrollment
1
Location
12
Duration (Months)
25
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

The purpose of this study is evaluate patients with acute myeloid leukemia (<=66 years), treated with conventional and experimental chemotherapy following allogeneic transplantation. THis patients have been enrolled from 2000 to 2011 at the Division of Hematology, Molinette University Hospital. The purpose of data collection is to assess, with retrospective analysis, the clinical outcome divided by risk class and evaluated in patients who achieve complete remission after induction therapy and consolidation.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    300 participants
    Observational Model:
    Case-Only
    Time Perspective:
    Retrospective
    Official Title:
    CONVENTIONAL AND EXPERIMENTAL CHEMOTHERAPY WITH ALLOGENEIC TRANSPLANT IN YOUNG PATIENTS WITH ACUTE MYELOID LEUKAEMIA
    Study Start Date :
    Feb 1, 2013
    Anticipated Primary Completion Date :
    Feb 1, 2014
    Anticipated Study Completion Date :
    Feb 1, 2014

    Arms and Interventions

    Arm Intervention/Treatment
    1

    Outcome Measures

    Primary Outcome Measures

    1. Overall survival [1 year]

    2. Event-free survival [1 year]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 66 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No

    Patients with acute myeloid leukemia (<=66 years), treated with conventional and experimental chemotherapy following allogeneic transplantation. THis patients have been enrolled from 2000 to 2011 at the Division of Hematology, Molinette University Hospital.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Città della Salute e della Scienza di Torino Torino Italy 10126

    Sponsors and Collaborators

    • Azienda Ospedaliera San Giovanni Battista

    Investigators

    • Principal Investigator: Benedetto Bruno, MD, Divisione di Ematologia-Città della Salute e della Scienza di Torino

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Benedetto Bruno, MD, Azienda Ospedaliera San Giovanni Battista
    ClinicalTrials.gov Identifier:
    NCT01785953
    Other Study ID Numbers:
    • AML-TO-2012
    First Posted:
    Feb 7, 2013
    Last Update Posted:
    Feb 7, 2013
    Last Verified:
    Feb 1, 2013
    Additional relevant MeSH terms:
    Leukemia
    Leukemia, Myeloid
    Leukemia, Myeloid, Acute

    Study Results

    No Results Posted as of Feb 7, 2013